Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Fk-614, 193012-35-0, Fk614, Atx08-001, V5q32bzx79, 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide

Molecular Formula

C₂₁H₂₃Cl₂N₃O₃S

Molecular Weight

468.4 g/mol

InChI Key

UYGZODVVDUIDDQ-UHFFFAOYSA-N

FDA UNII

V5Q32BZX79

FK614 has been used in trials studying the treatment of Diabetes Mellitus.

1 2D Structure

Fk 614

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[(2,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide

2.1.2 InChI

InChI=1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)15-7-9-19-20(11-15)26(14(2)24-19)13-16-6-8-17(22)12-18(16)23/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27)

2.1.3 InChI Key

UYGZODVVDUIDDQ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=C(C=C(C=C3)Cl)Cl)C

2.2 Other Identifiers

2.2.1 UNII

V5Q32BZX79

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide

2. Fk614 Cpd

2.3.2 Depositor-Supplied Synonyms

1. Fk-614

2. 193012-35-0

3. Fk614

4. Atx08-001

5. V5q32bzx79

6. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide

7. Unii-v5q32bzx79

8. Fk 614

9. Schembl682052

10. Chembl3545278

11. Dtxsid60940978

12. Bdbm50469398

13. Db12557

14. Sb16865

15. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide

16. 1-[(2,4-dichlorophenyl)methyl]-2-methyl-n-(pentane-1-sulfonyl)-1h-benzimidazole-6-carboximidic Acid

17. Hy-101292

18. Cs-0021092

19. A857643

20. Q27291562

21. 1-(2,4-dichlorobenzyl)-2-methyl-6-(1-pentanesulfonylcarbamoyl)benzimidazole

22. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxami-de

23. 3-[(2,4-dichlorophenyl)methyl]-2-methyl-n-pentylsulfonylbenzimidazole-5-carboxamide

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₃Cl₂N₃O₃S
Molecular Weight	468.4 g/mol
XLogP3	5.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	8
Exact Mass	467.0837182 g/mol
Monoisotopic Mass	467.0837182 g/mol
Topological Polar Surface Area	89.4 Å²
Heavy Atom Count	30
Formal Charge	0
Complexity	688
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1